Upload Image (Max 20MB per Image)
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk. The transaction includes Iberogast and Laif brands indicated for the treatment of functional gastrointestinal disorders and for the treatment of ...
Tags: Steigerwald Arzneimittelwerk, Medicine